Real life results of direct acting antiviral therapy for HCV infection in HIV–HCV-coinfected patients: Epi-Ter2 study - A. Piekarska, E. Jabłonowska, A. Garlicki, M. Sitko, W. Mazur, J. Jaroszewicz, A. Czauz-Andrzejuk, I. Buczyńska, K. Simon, B. Lorenc, D. Dybowska, W. Halota, M. Pawłowska, B. Dobracka, H. Berak - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

Published in

Taylor and Francis Group, AIDS Care, 6(32), p. 762-769, 2019

DOI: 10.1080/09540121.2019.1645808

Links

Tools

Export citation

Search in Google Scholar

Real life results of direct acting antiviral therapy for HCV infection in HIV–HCV-coinfected patients: Epi-Ter2 study

Journal article published in 2019 by A. Piekarska, E. Jabłonowska, A. Garlicki, M. Sitko, W. Mazur, J. Jaroszewicz, A. Czauz-Andrzejuk, I. Buczyńska, K. Simon, B. Lorenc, D. Dybowska, W. Halota, M. Pawłowska, B. Dobracka, H. Berak and other authors.

Distributing this paper is prohibited by the publisher

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle

Preprint: archiving forbidden

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO